Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02219555
7:13:chronic_disease
major trauma (fractures or complete ligamentous tears) to the study hand or wrist
3
[ "major", "trauma", "(", "fractures", "or", "complete", "ligamentous", "tears", ")", "to", "the", "study", "hand", "or", "wrist" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02543944
207:231:treatment
have an unstable medical condition or stable medical condition that would interact with study medications or participation, including a current chronic pain or other medical condition that requires ongoing opioid agonist treatment (determined by physician assessment)
3
[ "have", "an", "unstable", "medical", "condition", "or", "stable", "medical", "condition", "that", "would", "interact", "with", "study", "medications", "or", "participation", ",", "including", "a", "current", "chronic", "pain", "or", "other", "medical", "condition", "that", "requires", "ongoing", "opioid", "agonist", "treatment", "(", "determined", "by", "physician", "assessment", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02373644
42:69:treatment
Any indication that might contraindicate spinal manipulative therapy
3
[ "Any", "indication", "that", "might", "contraindicate", "spinal", "manipulative", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT00909909
4:29:cancer,69:103:cancer,111:118:cancer,122:130:cancer
No lobular carcinoma in situ alone (i.e., no invasive component) or non-epithelial breast malignancies (e.g., sarcoma or lymphoma)
3
[ "No", "lobular", "carcinoma", "in", "situ", "alone", "(", "i.e.", ",", "no", "invasive", "component", ")", "or", "non-epithelial", "breast", "malignancies", "(", "e.g.", ",", "sarcoma", "or", "lymphoma", ")" ]
[ 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 3, 0, 3, 0 ]
NCT02245997
30:43:cancer
Patients must have high-risk neuroblastoma as defined by the COG Risk Stratification Schema
3
[ "Patients", "must", "have", "high-risk", "neuroblastoma", "as", "defined", "by", "the", "COG", "Risk", "Stratification", "Schema" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01595529
70:81:allergy_name
A child with a known history of type I hypersensitivity of the study antibiotics to be prescribed
3
[ "A", "child", "with", "a", "known", "history", "of", "type", "I", "hypersensitivity", "of", "the", "study", "antibiotics", "to", "be", "prescribed" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0 ]
NCT02266745
10:30:chronic_disease,,,,,
Unstable cardiac dysrhythmias or persistent prolongation of the corrected QT interval (QTc) (Fridericia) to >450 msec for males or >470 msec for females
3
[ "Unstable", "cardiac", "dysrhythmias", "or", "persistent", "prolongation", "of", "the", "corrected", "QT", "interval", "(", "QTc", ")", "(", "Fridericia", ")", "to", ">", "450", "msec", "for", "males", "or", ">", "470", "msec", "for", "females" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01597518
96:107:treatment,132:149:treatment,153:161:treatment
Subject is currently using, and will continue to use for the next 14 days any of the following medications which are classified as CYP1A2 inhibitors or inducers
3
[ "Subject", "is", "currently", "using", ",", "and", "will", "continue", "to", "use", "for", "the", "next", "14", "days", "any", "of", "the", "following", "medications", "which", "are", "classified", "as", "CYP1A2", "inhibitors", "or", "inducers" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 1 ]
NCT03187951
24:38:treatment,
Anticipated to undergo pancreatectomy in >/= 6 weeks from enrollment
3
[ "Anticipated", "to", "undergo", "pancreatectomy", "in", ">", "/=", "6", "weeks", "from", "enrollment" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01626079
1:35:treatment,53:86:treatment,95:137:treatment
Prior mitral valve leaflet surgery or any currently implanted prosthetic mitral valve, or any prior transcatheter mitral valve procedure
3
[ "Prior", "mitral", "valve", "leaflet", "surgery", "or", "any", "currently", "implanted", "prosthetic", "mitral", "valve", ",", "or", "any", "prior", "transcatheter", "mitral", "valve", "procedure" ]
[ 1, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 1 ]
NCT02312245
1:15:treatment,22:27:treatment,29:38:treatment,40:46:treatment,50:68:treatment,92:98:cancer
Prior treatment with Doxil, topotecan, Gemzar or Taxol chemotherapy for platinum-resistant cancer
3
[ "Prior", "treatment", "with", "Doxil", ",", "topotecan", ",", "Gemzar", "or", "Taxol", "chemotherapy", "for", "platinum-resistant", "cancer" ]
[ 1, 1, 0, 1, 0, 1, 0, 1, 0, 1, 1, 0, 0, 3 ]
NCT01884740
13:18:cancer,43:56:treatment,79:95:cancer,124:136:treatment
A confirmed tumor site is one in which is biopsy-proven with the exception of brainstem glioma which will be eligible with radiographic diagnosis
3
[ "A", "confirmed", "tumor", "site", "is", "one", "in", "which", "is", "biopsy-proven", "with", "the", "exception", "of", "brainstem", "glioma", "which", "will", "be", "eligible", "with", "radiographic", "diagnosis" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 1, 0 ]
NCT02315196
14:35:treatment,59:84:treatment,147:166:chronic_disease
History of a major organ allograft or condition requiring chronic immunosuppression, e.g., kidney, liver, lung, heart, bone marrow transplant, or autoimmune diseases
3
[ "History", "of", "a", "major", "organ", "allograft", "or", "condition", "requiring", "chronic", "immunosuppression", ",", "e.g.", ",", "kidney", ",", "liver", ",", "lung", ",", "heart", ",", "bone", "marrow", "transplant", ",", "or", "autoimmune", "diseases" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02525692
5:12:treatment,28:55:treatment,64:81:treatment,
Any surgery (not including minor diagnostic procedures such as lymph node biopsy) within 2 weeks of baseline disease assessments; or not fully recovered from any side effects of previous procedures
3
[ "Any", "surgery", "(", "not", "including", "minor", "diagnostic", "procedures", "such", "as", "lymph", "node", "biopsy", ")", "within", "2", "weeks", "of", "baseline", "disease", "assessments", ";", "or", "not", "fully", "recovered", "from", "any", "side", "effects", "of", "previous", "procedures" ]
[ 0, 1, 0, 0, 0, 1, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02476409
1:8:chronic_disease
Ascites
3
[ "Ascites" ]
[ 2 ]
NCT02771626
1:14:treatment,
Major surgery within 28 days before Cycle 1 Day 1
3
[ "Major", "surgery", "within", "28", "days", "before", "Cycle", "1", "Day", "1" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03000257
26:44:treatment,55:67:treatment,69:82:treatment,84:101:treatment,103:111:treatment,113:127:treatment,136:159:treatment,,220:228:treatment,232:255:treatment
Participant has received anticancer therapy including chemotherapy, immunotherapy, radiation therapy, biologic, herbal therapy, or any investigational therapy within a period of 5 half-lives, prior to the first dose of ABBV-181 or Rovalpituzumab Tesirine
3
[ "Participant", "has", "received", "anticancer", "therapy", "including", "chemotherapy", ",", "immunotherapy", ",", "radiation", "therapy", ",", "biologic", ",", "herbal", "therapy", ",", "or", "any", "investigational", "therapy", "within", "a", "period", "of", "5", "half-lives", ",", "prior", "to", "the", "first", "dose", "of", "ABBV-181", "or", "Rovalpituzumab", "Tesirine" ]
[ 0, 0, 0, 1, 1, 0, 1, 0, 1, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1 ]
NCT02414178
255:279:chronic_disease
Has any condition that, in the Investigator's opinion, could increase risk to the participant, limit the participant's ability to tolerate the experimental procedures, or interfere with the collection/analysis of the data (for example, participants with severe chronic back pain might not be able to lie still during the scanning procedures)
3
[ "Has", "any", "condition", "that", ",", "in", "the", "Investigator", "'s", "opinion", ",", "could", "increase", "risk", "to", "the", "participant", ",", "limit", "the", "participant", "'s", "ability", "to", "tolerate", "the", "experimental", "procedures", ",", "or", "interfere", "with", "the", "collection/analysis", "of", "the", "data", "(", "for", "example", ",", "participants", "with", "severe", "chronic", "back", "pain", "might", "not", "be", "able", "to", "lie", "still", "during", "the", "scanning", "procedures", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02181257
38:58:allergy_name
Known allergy or hypersensitivity to pharmacologic agents used during ECP
3
[ "Known", "allergy", "or", "hypersensitivity", "to", "pharmacologic", "agents", "used", "during", "ECP" ]
[ 0, 0, 0, 0, 0, 4, 4, 0, 0, 0 ]
NCT03118050
22:46:chronic_disease
Non-diabetic or with Type 2 Diabetes Mellitus
3
[ "Non-diabetic", "or", "with", "Type", "2", "Diabetes", "Mellitus" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT01072370
13:38:chronic_disease
Presence of obstructive hydrocephalus
3
[ "Presence", "of", "obstructive", "hydrocephalus" ]
[ 0, 0, 2, 2 ]
NCT02520791
102:110:allergy_name,125:136:chronic_disease,144:164:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MEDI-570 or history of anaphylaxis to any biological component
3
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "MEDI-570", "or", "history", "of", "anaphylaxis", "to", "any", "biological", "component" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 2, 0, 0, 4, 4 ]
NCT02098876
1:14:chronic_disease,18:33:chronic_disease,25:33:chronic_disease,,116:130:treatment,132:144:treatment,146:160:treatment,157:160:treatment,194:214:chronic_disease
stable angina or silent ischemia and < 70% diameter stenosis must have objective sign of ischemia as determined by echocardiogram, nuclear scan, ambulatory ECG or stress ECG. In the absence of noninvasive ischemia, fractional flow reserve (FFR) must be done and indicative of ischemia
3
[ "stable", "angina", "or", "silent", "ischemia", "and", "<", "70", "%", "diameter", "stenosis", "must", "have", "objective", "sign", "of", "ischemia", "as", "determined", "by", "echocardiogram", ",", "nuclear", "scan", ",", "ambulatory", "ECG", "or", "stress", "ECG", ".", "In", "the", "absence", "of", "noninvasive", "ischemia", ",", "fractional", "flow", "reserve", "(", "FFR", ")", "must", "be", "done", "and", "indicative", "of", "ischemia" ]
[ 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02253316
8:27:chronic_disease,28:43:chronic_disease,54:88:chronic_disease
Active hepatitis A, B or C virus infection, or known human immunodeficiency virus (HIV) positive
3
[ "Active", "hepatitis", "A", ",", "B", "or", "C", "virus", "infection", ",", "or", "known", "human", "immunodeficiency", "virus", "(", "HIV", ")", "positive" ]
[ 0, 2, 2, 2, 2, 2, 0, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0 ]
NCT03181893
,33:43:treatment
Intake of greater than 15 mg of prednisone or equivalent per day
3
[ "Intake", "of", "greater", "than", "15", "mg", "of", "prednisone", "or", "equivalent", "per", "day" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02924402
33:87:treatment
Not a candidate for or refusing treatment with hematopoietic stem cell transplantation
3
[ "Not", "a", "candidate", "for", "or", "refusing", "treatment", "with", "hematopoietic", "stem", "cell", "transplantation" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1 ]
NCT02863991
,,,,70:74:treatment
Platelets ≥75,000/mm3 without platelet transfusion ≤ 3 days prior to C1D1
3
[ "Platelets", "≥75,000/mm3", "without", "platelet", "transfusion", "≤", "3", "days", "prior", "to", "C1D1" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02356653
1:24:cancer
Myelodyplastic syndrome
3
[ "Myelodyplastic", "syndrome" ]
[ 3, 3 ]
NCT02945800
1:33:treatment,77:93:treatment,118:147:treatment
Biologic (anti-neoplastic agent): 7 day must have elapsed from the start of protocol therapy since the completion of therapy with a biologic agent
3
[ "Biologic", "(", "anti-neoplastic", "agent", ")", ":", "7", "day", "must", "have", "elapsed", "from", "the", "start", "of", "protocol", "therapy", "since", "the", "completion", "of", "therapy", "with", "a", "biologic", "agent" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02584309
1:17:cancer
Myxofibrosarcoma
3
[ "Myxofibrosarcoma" ]
[ 3 ]
NCT02484404
23:133:treatment
Patients who have had prior immune checkpoint inhibitors, such as MEDI4736 or other PD1 or PD-L1 inhibitors or an anti-CTLA4 therapy are not eligible
3
[ "Patients", "who", "have", "had", "prior", "immune", "checkpoint", "inhibitors", ",", "such", "as", "MEDI4736", "or", "other", "PD1", "or", "PD-L1", "inhibitors", "or", "an", "anti-CTLA4", "therapy", "are", "not", "eligible" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0 ]
NCT02585973
1:45:chronic_disease,49:59:chronic_disease,107:114:treatment,122:141:chronic_disease,156:162:chronic_disease,164:172:chronic_disease,174:182:chronic_disease,184:206:chronic_disease,211:232:treatment
Impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of AZD1775 (e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection)
3
[ "Impairment", "of", "gastrointestinal", "(", "GI", ")", "function", "or", "GI", "disease", "that", "may", "significantly", "alter", "the", "absorption", "of", "AZD1775", "(", "e.g.", ",", "ulcerative", "diseases", ",", "uncontrolled", "nausea", ",", "vomiting", ",", "diarrhea", ",", "malabsorption", "syndrome", ",", "or", "small", "bowel", "resection", ")" ]
[ 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 2, 2, 0, 0, 2, 0, 2, 0, 2, 0, 2, 2, 0, 0, 1, 1, 1, 0 ]
NCT03073343
7:51:chronic_disease
Known cystathionine beta-synthase (CBS) deficiency
3
[ "Known", "cystathionine", "beta-synthase", "(", "CBS", ")", "deficiency" ]
[ 0, 2, 2, 2, 2, 0, 0 ]
NCT02301546
1:26:chronic_disease
Mild Cognitive Impairment
3
[ "Mild", "Cognitive", "Impairment" ]
[ 2, 2, 2 ]
NCT02304458
47:60:cancer
Part B1: patients with relapsed or refractory neuroblastoma
3
[ "Part", "B1", ":", "patients", "with", "relapsed", "or", "refractory", "neuroblastoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02503358
5:61:treatment,66:74:cancer,78:94:cancer
Any prior treatment with either a MEK, RAS, or RAF inhibitor for advanced or metastatic NSCLC
3
[ "Any", "prior", "treatment", "with", "either", "a", "MEK", ",", "RAS", ",", "or", "RAF", "inhibitor", "for", "advanced", "or", "metastatic", "NSCLC" ]
[ 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 3, 0, 3, 3 ]
NCT02496663
,93:106:chronic_disease,121:148:chronic_disease,132:148:chronic_disease,,,268:290:treatment,334:353:chronic_disease
Any factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, hypokalemia, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age in first degree relatives or any concomitant medication known to prolong the QT interval and cause torsades de pointes
3
[ "Any", "factors", "that", "increase", "the", "risk", "of", "QTc", "prolongation", "or", "risk", "of", "arrhythmic", "events", "such", "as", "heart", "failure", ",", "hypokalemia", ",", "congenital", "long", "QT", "syndrome", ",", "family", "history", "of", "long", "QT", "syndrome", "or", "unexplained", "sudden", "death", "under", "40", "years", "of", "age", "in", "first", "degree", "relatives", "or", "any", "concomitant", "medication", "known", "to", "prolong", "the", "QT", "interval", "and", "cause", "torsades", "de", "pointes" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT00809991
7:37:chronic_disease
Major medical or psychiatric illness which, in the investigator's opinion, would prevent completion of treatment and would interfere with follow up
3
[ "Major", "medical", "or", "psychiatric", "illness", "which", ",", "in", "the", "investigator", "'s", "opinion", ",", "would", "prevent", "completion", "of", "treatment", "and", "would", "interfere", "with", "follow", "up" ]
[ 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02451423
1:4:chronic_disease
HBV DNA must be obtained in these patients prior to Cycle 1, Day 1, but detection of HBV DNA in these patients will not exclude study participation
3
[ "HBV", "DNA", "must", "be", "obtained", "in", "these", "patients", "prior", "to", "Cycle", "1", ",", "Day", "1", ",", "but", "detection", "of", "HBV", "DNA", "in", "these", "patients", "will", "not", "exclude", "study", "participation" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01028846
8:19:chronic_disease
stable retinopathy
3
[ "stable", "retinopathy" ]
[ 0, 2 ]
NCT02433977
1:22:chronic_disease,,
Chronic renal failure (creatinine > 2.0) at screening (Associated with higher ADMA levels)
3
[ "Chronic", "renal", "failure", "(", "creatinine", ">", "2.0", ")", "at", "screening", "(", "Associated", "with", "higher", "ADMA", "levels", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02310633
5:19:chronic_disease
not claustrophobic
3
[ "not", "claustrophobic" ]
[ 0, 2 ]
NCT02561988
13:24:treatment,,,
most recent transfusion occurring during the preceding 4 weeks and transfusion administered for hemoglobin ≤ 8.5 g/dL
3
[ "most", "recent", "transfusion", "occurring", "during", "the", "preceding", "4", "weeks", "and", "transfusion", "administered", "for", "hemoglobin", "≤", "8.5", "g/dL" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01639508
1:21:chronic_disease,32:59:treatment,44:59:treatment
thromboembolic event requiring therapeutic anticoagulation except if anticoagulation is as stipulated in Exclusion Criterium #6
3
[ "thromboembolic", "event", "requiring", "therapeutic", "anticoagulation", "except", "if", "anticoagulation", "is", "as", "stipulated", "in", "Exclusion", "Criterium", "#", "6" ]
[ 2, 2, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01341080
3:27:treatment,,53:99:treatment,109:135:chronic_disease,147:168:chronic_disease,172:187:chronic_disease,243:255:chronic_disease,269:317:chronic_disease,319:346:chronic_disease,352:368:treatment,380:404:chronic_disease,,,
A cardiovascular procedure in the last 5 years (eg, percutaneous transluminal coronary angioplasty) or have cardiovascular instability (including myocardial infarction or unstable angina). Other cardiovascular exclusions include uncontrolled hypertension, significant neurological sequelae of cerebrovascular disease, peripheral vascular disease with prior amputation, or severe congestive heart failure (New York Heart Association class III or IV)
3
[ "A", "cardiovascular", "procedure", "in", "the", "last", "5", "years", "(", "eg", ",", "percutaneous", "transluminal", "coronary", "angioplasty", ")", "or", "have", "cardiovascular", "instability", "(", "including", "myocardial", "infarction", "or", "unstable", "angina", ")", ".", "Other", "cardiovascular", "exclusions", "include", "uncontrolled", "hypertension", ",", "significant", "neurological", "sequelae", "of", "cerebrovascular", "disease", ",", "peripheral", "vascular", "disease", "with", "prior", "amputation", ",", "or", "severe", "congestive", "heart", "failure", "(", "New", "York", "Heart", "Association", "class", "III", "or", "IV", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 2, 2, 2, 2, 2, 0, 2, 2, 2, 0, 1, 1, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02991651
62:97:cancer
Patients must have histologically or cytologically confirmed stage IV non-small cell lung cancer
3
[ "Patients", "must", "have", "histologically", "or", "cytologically", "confirmed", "stage", "IV", "non-small", "cell", "lung", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 3 ]
NCT01505062
12:35:treatment
Concurrent anti-retroviral therapy that would inactivate the investigational agent
3
[ "Concurrent", "anti-retroviral", "therapy", "that", "would", "inactivate", "the", "investigational", "agent" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01967823
12:36:treatment
Concurrent systemic steroid therapy
3
[ "Concurrent", "systemic", "steroid", "therapy" ]
[ 0, 1, 1, 1 ]
NCT02549937
1:35:treatment,,78:103:treatment,115:127:treatment,129:149:treatment,151:165:treatment,167:177:treatment,182:195:treatment
Systemic anti-neoplastic therapies within 4 weeks prior to the initiation of investigational treatment, including chemotherapy, radical radiotherapy, hormonotherapy, biotherapy and immunotherapy
3
[ "Systemic", "anti-neoplastic", "therapies", "within", "4", "weeks", "prior", "to", "the", "initiation", "of", "investigational", "treatment", ",", "including", "chemotherapy", ",", "radical", "radiotherapy", ",", "hormonotherapy", ",", "biotherapy", "and", "immunotherapy" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 1, 1, 0, 1, 0, 1, 0, 1 ]
NCT02283333
13:26:treatment,31:35:chronic_disease,43:53:chronic_disease
enrolled in another trial for PTSD and/or depression
3
[ "enrolled", "in", "another", "trial", "for", "PTSD", "and/or", "depression" ]
[ 0, 0, 1, 1, 0, 2, 0, 2 ]
NCT02842658
1:18:chronic_disease
Acute myocarditis
3
[ "Acute", "myocarditis" ]
[ 2, 2 ]
NCT02937350
1:13:chronic_disease
Tuberculosis
3
[ "Tuberculosis" ]
[ 2 ]
NCT02927301
27:139:cancer
Pathologically documented Stage IB, II, IIIA, or selected IIIB, including T3N2 or T4 (by size criteria, not by mediastinal invasion) NSCLC
3
[ "Pathologically", "documented", "Stage", "IB", ",", "II", ",", "IIIA", ",", "or", "selected", "IIIB", ",", "including", "T3N2", "or", "T4", "(", "by", "size", "criteria", ",", "not", "by", "mediastinal", "invasion", ")", "NSCLC" ]
[ 0, 0, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562066
38:72:treatment
In patients previously stabilized on 3,4-DAP or amifampridine phosphate, history of meaningful improvement in motor function (in opinion of investigator)
3
[ "In", "patients", "previously", "stabilized", "on", "3,4-DAP", "or", "amifampridine", "phosphate", ",", "history", "of", "meaningful", "improvement", "in", "motor", "function", "(", "in", "opinion", "of", "investigator", ")" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02366871
13:26:chronic_disease,,
Significant liver disease as defined as Aspartate Transaminase (AST) or Alanine Transaminase (ALT) twice than normal
3
[ "Significant", "liver", "disease", "as", "defined", "as", "Aspartate", "Transaminase", "(", "AST", ")", "or", "Alanine", "Transaminase", "(", "ALT", ")", "twice", "than", "normal" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01872975
31:38:treatment,43:56:cancer,68:90:treatment,96:109:treatment,
The interval between the last surgery for breast cancer (including re-excision of margins) and randomization must be no more than 70 days
3
[ "The", "interval", "between", "the", "last", "surgery", "for", "breast", "cancer", "(", "including", "re-excision", "of", "margins", ")", "and", "randomization", "must", "be", "no", "more", "than", "70", "days" ]
[ 0, 0, 0, 0, 0, 1, 0, 3, 3, 0, 0, 1, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01894061
69:80:chronic_disease,82:90:chronic_disease,95:101:chronic_disease
Evidence of increased intracranial pressure (clinically significant papilledema, vomiting and nausea or reduced level of consciousness)
3
[ "Evidence", "of", "increased", "intracranial", "pressure", "(", "clinically", "significant", "papilledema", ",", "vomiting", "and", "nausea", "or", "reduced", "level", "of", "consciousness", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT02498613
29:56:treatment
the clinical indication for therapeutic anticoagulation must be clearly documented prior to enrollment and must be discussed with the P.I
3
[ "the", "clinical", "indication", "for", "therapeutic", "anticoagulation", "must", "be", "clearly", "documented", "prior", "to", "enrollment", "and", "must", "be", "discussed", "with", "the", "P.I" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02188745
24:42:cancer,71:77:treatment,172:186:cancer
Patients with non-bone metastatic disease in whom a safe and accurate biopsy of recurrent/metastatic disease cannot be readily obtained are also eligible, providing their primary cancer is consistent with the above-described ER and HER2 criteria
3
[ "Patients", "with", "non-bone", "metastatic", "disease", "in", "whom", "a", "safe", "and", "accurate", "biopsy", "of", "recurrent/metastatic", "disease", "can", "not", "be", "readily", "obtained", "are", "also", "eligible", ",", "providing", "their", "primary", "cancer", "is", "consistent", "with", "the", "above-described", "ER", "and", "HER2", "criteria" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00338065
15:36:chronic_disease
Patients with autonomic dysfunction
3
[ "Patients", "with", "autonomic", "dysfunction" ]
[ 0, 0, 2, 2 ]
NCT02130687
19:23:chronic_disease,,
Poorly controlled T2DM, defined as Hgb A1C>8.7%
3
[ "Poorly", "controlled", "T2DM", ",", "defined", "as", "Hgb", "A1C", ">", "8.7", "%" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01850355
1:24:chronic_disease
Organic brain disorders
3
[ "Organic", "brain", "disorders" ]
[ 2, 2, 2 ]
NCT02860000
1:14:treatment,
Immunotherapy =< 21 days
3
[ "Immunotherapy", "=", "<", "21", "days" ]
[ 1, 0, 0, 0, 0 ]
NCT02232516
1:20:chronic_disease
Psychiatric illness/social situations that would limit compliance with study requirements
3
[ "Psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02891447
9:27:cancer,55:77:cancer,79:84:cancer,86:108:cancer,110:114:cancer
Distant metastatic disease not limited to peritoneum: Solid organ metastases (liver, central nervous system, lung)
3
[ "Distant", "metastatic", "disease", "not", "limited", "to", "peritoneum", ":", "Solid", "organ", "metastases", "(", "liver", ",", "central", "nervous", "system", ",", "lung", ")" ]
[ 0, 3, 3, 0, 0, 0, 0, 0, 3, 3, 3, 0, 3, 0, 3, 3, 3, 0, 3, 0 ]
NCT02589977
1:18:chronic_disease
diabetes mellitus
3
[ "diabetes", "mellitus" ]
[ 2, 2 ]
NCT01811368
1:35:chronic_disease
Human immunodeficiency virus (HIV)-positive patients
3
[ "Human", "immunodeficiency", "virus", "(", "HIV", ")", "-positive", "patients" ]
[ 2, 2, 2, 2, 0, 0, 0, 0 ]
NCT01811368
23:35:treatment,39:51:treatment,,,80:92:treatment,96:107:treatment
Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study
3
[ "Patients", "who", "have", "had", "chemotherapy", "or", "radiotherapy", "within", "4", "weeks", "(", "6", "weeks", "for", "nitrosoureas", "or", "mitomycin", "C", ")", "prior", "to", "entering", "the", "study" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02501096
1:31:chronic_disease,33:61:chronic_disease,122:132:treatment
Gastrointestinal malabsorption, gastrointestinal anastomosis, or any other condition that might affect the absorption of lenvatinib
3
[ "Gastrointestinal", "malabsorption", ",", "gastrointestinal", "anastomosis", ",", "or", "any", "other", "condition", "that", "might", "affect", "the", "absorption", "of", "lenvatinib" ]
[ 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01714596
15:37:chronic_disease
Patients with traumatic brain injury or who are intellectually challenged and who lack adequate family support to ensure adherence to the protocol
3
[ "Patients", "with", "traumatic", "brain", "injury", "or", "who", "are", "intellectually", "challenged", "and", "who", "lack", "adequate", "family", "support", "to", "ensure", "adherence", "to", "the", "protocol" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01880567
17:20:cancer,,
Newly diagnosed MCL: Serum bilirubin < 1.5 mg/dl
3
[ "Newly", "diagnosed", "MCL", ":", "Serum", "bilirubin", "<", "1.5", "mg/dl" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT02842658
59:72:treatment,79:91:treatment,93:104:treatment,109:125:treatment
Subjects must be scheduled by their oncologist to undergo anthracycline based chemotherapy (doxorubicin and cyclophosphamide) in the neoadjuvant/adjuvant setting
3
[ "Subjects", "must", "be", "scheduled", "by", "their", "oncologist", "to", "undergo", "anthracycline", "based", "chemotherapy", "(", "doxorubicin", "and", "cyclophosphamide", ")", "in", "the", "neoadjuvant/adjuvant", "setting" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
NCT02166905
31:65:treatment,60:64:treatment,118:128:treatment,130:139:treatment,141:155:treatment,
Subjects being treated with a monoamine oxidase inhibitor (MAOI), or drug which has significant MAOI activity (e.g., Meperidine, linezolid, methylene blue) within 3 weeks prior to screening
3
[ "Subjects", "being", "treated", "with", "a", "monoamine", "oxidase", "inhibitor", "(", "MAOI", ")", ",", "or", "drug", "which", "has", "significant", "MAOI", "activity", "(", "e.g.", ",", "Meperidine", ",", "linezolid", ",", "methylene", "blue", ")", "within", "3", "weeks", "prior", "to", "screening" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02576444
1:24:treatment,7:24:treatment,,135:144:treatment
Prior radiation therapy is allowed. Patients must not have received radiation therapy within 21 days prior to the initiation of study treatment
3
[ "Prior", "radiation", "therapy", "is", "allowed", ".", "Patients", "must", "not", "have", "received", "radiation", "therapy", "within", "21", "days", "prior", "to", "the", "initiation", "of", "study", "treatment" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01494662
32:66:treatment,87:99:treatment,101:113:treatment,118:134:treatment,162:171:treatment,177:192:treatment,197:206:treatment,227:237:cancer,285:294:treatment
Patients who are receiving any cancer-directed concurrent therapy, such as concurrent chemotherapy, radiotherapy, or hormonal therapy while on study. Concurrent treatment with bisphosphonates and denosumab is allowed for bony metastases but should be started before the first dose of neratinib
3
[ "Patients", "who", "are", "receiving", "any", "cancer-directed", "concurrent", "therapy", ",", "such", "as", "concurrent", "chemotherapy", ",", "radiotherapy", ",", "or", "hormonal", "therapy", "while", "on", "study", ".", "Concurrent", "treatment", "with", "bisphosphonates", "and", "denosumab", "is", "allowed", "for", "bony", "metastases", "but", "should", "be", "started", "before", "the", "first", "dose", "of", "neratinib" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02353819
21:69:treatment
Deemed eligible for Complete Androgen Blockade (CAB) hormone therapy by treating physician, including baseline liver function evaluation
3
[ "Deemed", "eligible", "for", "Complete", "Androgen", "Blockade", "(", "CAB", ")", "hormone", "therapy", "by", "treating", "physician", ",", "including", "baseline", "liver", "function", "evaluation" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03035890
1:25:chronic_disease
unstable angina pectoris
3
[ "unstable", "angina", "pectoris" ]
[ 2, 2, 2 ]
NCT02435992
21:46:chronic_disease
Clinically relevant cardiovascular conditions or other relevant diseases that could impact the implementation or interpretation of the trial, or put the patient at risk
3
[ "Clinically", "relevant", "cardiovascular", "conditions", "or", "other", "relevant", "diseases", "that", "could", "impact", "the", "implementation", "or", "interpretation", "of", "the", "trial", ",", "or", "put", "the", "patient", "at", "risk" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02226159
7:13:chronic_disease
acute trauma
3
[ "acute", "trauma" ]
[ 0, 2 ]
NCT01584076
1:7:chronic_disease,
Myopia more than -6.00 D spherical equivalent
3
[ "Myopia", "more", "than", "-6.00", "D", "spherical", "equivalent" ]
[ 2, 0, 0, 0, 0, 0, 0 ]
NCT02520791
29:65:treatment,
Patients who have undergone autologous stem cell transplantation within 3 months from study entry
3
[ "Patients", "who", "have", "undergone", "autologous", "stem", "cell", "transplantation", "within", "3", "months", "from", "study", "entry" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01422746
1:13:chronic_disease
Virilization
3
[ "Virilization" ]
[ 2 ]
NCT02252588
1:22:chronic_disease
Active oral infection being treated by health care professional
3
[ "Active", "oral", "infection", "being", "treated", "by", "health", "care", "professional" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02440581
7:31:chronic_disease
Known Paget 's disease of bone
3
[ "Known", "Paget", "'s", "disease", "of", "bone" ]
[ 0, 2, 2, 2, 2, 2 ]
NCT03070535
1:23:chronic_disease,32:69:chronic_disease,71:81:chronic_disease,87:94:chronic_disease,143:150:treatment
Psychiatric conditions such as post-traumatic stress disorder (PTSD), depression, and anxiety which are stable and treated with medication or therapy are ok
3
[ "Psychiatric", "conditions", "such", "as", "post-traumatic", "stress", "disorder", "(", "PTSD", ")", ",", "depression", ",", "and", "anxiety", "which", "are", "stable", "and", "treated", "with", "medication", "or", "therapy", "are", "ok" ]
[ 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT02043548
16:31:treatment,45:54:treatment,56:65:treatment,67:76:treatment,89:105:treatment,109:120:treatment,124:160:treatment
No concomitant biologic agents are allowed (rituximab, anti-TNFs, abatacept) as well as cyclophosphamide or tofacitinib as concomitant immunosuppressive agents
3
[ "No", "concomitant", "biologic", "agents", "are", "allowed", "(", "rituximab", ",", "anti-TNFs", ",", "abatacept", ")", "as", "well", "as", "cyclophosphamide", "or", "tofacitinib", "as", "concomitant", "immunosuppressive", "agents" ]
[ 0, 1, 1, 1, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0 ]
NCT03011307
,39:47:treatment
Taking greater than 100 milligrams of morphine (or equivalent)
3
[ "Taking", "greater", "than", "100", "milligrams", "of", "morphine", "(", "or", "equivalent", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT01676753
,14:58:treatment
> 2 lines of prior chemotherapy in the metastatic setting
3
[ ">", "2", "lines", "of", "prior", "chemotherapy", "in", "the", "metastatic", "setting" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1 ]
NCT02962895
10:21:chronic_disease,23:34:chronic_disease,36:39:chronic_disease,43:55:chronic_disease
Positive hepatitis B, hepatitis C, HIV or tuberculosis test results at screening
3
[ "Positive", "hepatitis", "B", ",", "hepatitis", "C", ",", "HIV", "or", "tuberculosis", "test", "results", "at", "screening" ]
[ 0, 2, 2, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0 ]
NCT02389309
,,35:46:treatment,
Hemoglobin greater than 8.0 g/dL (transfusion independent; no transfusion for >= 7 days prior to study enrollment)
3
[ "Hemoglobin", "greater", "than", "8.0", "g/dL", "(", "transfusion", "independent", ";", "no", "transfusion", "for", ">", "=", "7", "days", "prior", "to", "study", "enrollment", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02312596
8:21:chronic_disease
Severe liver disease
3
[ "Severe", "liver", "disease" ]
[ 0, 2, 2 ]
NCT02587962
,,,130:140:treatment
Currently breast feeding, pregnant or planning to conceive or father Children from screening through 120 Days after last dose of study drug
3
[ "Currently", "breast", "feeding", ",", "pregnant", "or", "planning", "to", "conceive", "or", "father", "Children", "from", "screening", "through", "120", "Days", "after", "last", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01280669
16:26:treatment,,69:83:treatment,95:121:treatment
combination of prednisone <10 mg/day (or equivalent dose of another corticosteroid) and other systemic immunosuppressant
3
[ "combination", "of", "prednisone", "<", "10", "mg/day", "(", "or", "equivalent", "dose", "of", "another", "corticosteroid", ")", "and", "other", "systemic", "immunosuppressant" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1 ]
NCT02946892
12:28:chronic_disease
Concurrent terminal illness
3
[ "Concurrent", "terminal", "illness" ]
[ 0, 2, 2 ]
NCT03128008
30:50:allergy_name
Medical contraindications to thoracic irradiation
3
[ "Medical", "contraindications", "to", "thoracic", "irradiation" ]
[ 0, 0, 0, 4, 4 ]
NCT02343042
,27:52:treatment,54:72:treatment,105:107:cancer
Patients who received ≥ 1 prior therapeutic regimen (prior lenalidomide is allowed as long as patient's MM was not refractory to prior lenalidomide
3
[ "Patients", "who", "received", "≥", "1", "prior", "therapeutic", "regimen", "(", "prior", "lenalidomide", "is", "allowed", "as", "long", "as", "patient", "'s", "MM", "was", "not", "refractory", "to", "prior", "lenalidomide" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT02129348
1:4:treatment,17:40:chronic_disease,42:55:chronic_disease,57:64:chronic_disease,66:89:chronic_disease
MRI findings of cerebrovascular disease (smallinfarcts, lacunes, periventricular disease)
3
[ "MRI", "findings", "of", "cerebrovascular", "disease", "(", "smallinfarcts", ",", "lacunes", ",", "periventricular", "disease", ")" ]
[ 1, 0, 0, 2, 2, 0, 2, 0, 2, 0, 2, 2, 0 ]
NCT02495545
14:23:chronic_disease
Diagnosis of acute SCI
3
[ "Diagnosis", "of", "acute", "SCI" ]
[ 0, 0, 2, 2 ]
NCT02862210
37:60:chronic_disease
Subjects with MRI or CT evidence of cerebrovascular disease but without clinical signs of stroke
3
[ "Subjects", "with", "MRI", "or", "CT", "evidence", "of", "cerebrovascular", "disease", "but", "without", "clinical", "signs", "of", "stroke" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02193373
1:9:chronic_disease
Diabetes
3
[ "Diabetes" ]
[ 2 ]